Topiramate treatment in bulimia nervosa patients: A randomized, double-blind, placebo-controlled trial

International Journal of Eating Disorders

Volumn 38, Issue 4, 2005, Pages 295-300

  Nickel, Cerstin ^b   Tritt, Karin ^d   Muehlbacher, Moritz ^c   Gil, Francisco Pedrosa ^e   Mitterlehner, Ferdinand O ^b   Kaplan, Patrick ^c   Lahmann, Claas ^d   Leiberich, Peter K ^d   Krawczyk, Jakub ^c   Kettler, Christian ^b   Rother, Wolfhardt K ^b   Loew, Thomas H ^d   Nickel, Marius K ^a,b,c,d  

^a Inntalklinik ^*  (Germany)

^b Clinic for Psychosomatic Medicine   (Germany)

^c University Clinic for Psychiatry   (Austria)

^d UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^e UNIVERSITY OF MUNICH   (Germany)

Author keywords

Body weight; Bulimia nervosa; Frequency of binging purging; Health related quality of life; Topiramate

Indexed keywords

PLACEBO; TOPIRAMATE;

ADULT; ARTICLE; BEHAVIOR; BODY WEIGHT; BULIMIA; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEADACHE; HUMAN; PARESTHESIA; PRIORITY JOURNAL; PSYCHOSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SEDATION; SHORT FORM 36; SIDE EFFECT; STATISTICAL SIGNIFICANCE; SUICIDAL BEHAVIOR; TREATMENT OUTCOME; VOMITING; WEIGHT REDUCTION;

ADOLESCENT; ADULT; ANTICONVULSANTS; ATTITUDE TO HEALTH; BULIMIA; COMORBIDITY; DOUBLE-BLIND METHOD; FEMALE; FRUCTOSE; HEALTH BEHAVIOR; HUMANS; PERSONALITY ASSESSMENT; PSYCHOMETRICS; TREATMENT OUTCOME;

EID: 28944433610     PISSN: 02763478     EISSN: None     Source Type: Journal    
DOI: 10.1002/eat.20202     Document Type: Article

References (23)

1. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washinton, DC: Author.
2. Appolinario, J.C., & McElroy S.L (2004). Pharmacological approaches in the treatment of binge eating disorder. Current Drug Targets, 5, 301-307.
3. Barbee, J.G. (2003). Topiramate in the treatment of severe bulimia nervosa with comorbid mood disorders: A case series. International Journal of Eating Disorders, 33, 468-472.
4. Berlant, J.L. (2001). Topiramate in posttraumatic stress disorder: Preliminary clinical observations. Journal of Clinical Psychiatry, 62(Suppl. 17), 60-63.
5. Bischofs, S., Zelenka, M., & Sommer, C. (2004). Evaluation of topiramate as an anti-hyperalgesic and neuroprotective agent in the peripheral nervous system. Journal of Periphery Nervous System, 9, 70-78.
6. Bozikas, V.P., Petrikis, P., Kourtis, A., Youlis, P., & Karavatos, A. (2002). Treatment of acute mania with topiramate in hospitalized patients. Progress in Neuropsychopharmacology and Biological Psychiatry, 26, 1203-1206.
7. Bullinger, M., & Kirchberger, I. (1998). Fragebogen zum Gesundheitszustand, SF-36 [SF-36 Health Survey], Goettingen: Hogrefe.
8. Casper, R.C. (2002). How useful are pharmacological treatments in eating disorders? Psychopharmacological Bulletin, 36, 88-104.
9. Danzl, C., Kemmler, G., Gottwald, E., Mangweth, B., Kintl, J., & Biebl, W. (2001). Quality of life of patients with eating disorders. A catamnestic study. Psychiatrische Praxis, 28, 18-23.
10. Hay, P. (2003). Quality of life and bulimic eating disorder behaviours: Finding from a community-based sample. International Journal of Eatings Disorders, 33, 434-441.
11. Hedges, D.W., Reimherr, F.W., Hoopes, S.P., Rosenthal, N.R., Kamin, M., Karim, R., & Capece, J.A. (2003). Treatment of bulimia nervosa with topiramte in a randomized, double-blind, placebo-controlled trial, part 2: Improvement in psychiatric measures. Journal of Clinical Psychiatry, 64, 1449-1454.
12. Hoopes, S.P., Reimherr, F.W., Hedges, D.W., Rosenthal, N.R., Kamin, M., Karim, R., Capece, J.A., & Karvois, D. (2003). Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, parti: Improvement in binge and purge measures. Journal of Clinical Psychiatry, 64, 1335-1341.
13. Kjelsas, E., Bjornstrom, C., & Gotestam, K.G. (2004). Prevalence of eating disorders in female and male adolescents (14-15 years). Eating Behavior, 5, 13-25.
14. Klein, D., & Walsh, B.T. (2004). Eating disorders: Clinical features and pathophysiology. Physiological Behavior, 81, 359-374.
15. Lyn, P. (2002). Eating disorders: A review of the literature with emphasis on medical complications and clinical nutrition. Alternative Medicine Review, 7, 184-202.
16. Marchesini, G., Natale, S., Chierici, S., Manini, R., Besteghi, L, Di Domizio, S., Sartini, A., Pasqui, F., Baraldi, L., Forlani, G., & Melchionda, N. (2002). Effects of cognitive-behavioural therapy on health-related quality of life in obese subjects with and without binge eating disorder. International Journal of Obesity Related Metabolic Disorders, 26, 1261-1267.
17. Mitchell, J.E., de Zwaan, M., & Roerig, J.L. (2003). Drug therapy for patients with eating disorders. Current Drug Targets. CNS and Neurological Disorders, 2, 17-29.
18. Muellner, M. (2002). Evidence based medicine. Wien: Springer.
19. Nickel, M., Nickel, C., Mitterlehner, F., Tritt, K., Lahmann, C., Leiberich, P., Rother, W., & Loew, T. (2004). Treatment of aggression in female borderline personality disorder patients: A double-blind, placebo-controlled study. Journal of Clinical Psychiatry, 65, 1515-1519.
20. Pederson, K.J., Roerig, J.L., & Mitchell, J.E. (2003). Towards the pharmacotherapy of eating disorders. Expert Opinion on Pharmacotherapy, 4, 1659-1678.
21. Shapira, N.A., Goldsmith, T.D., & McElroy, S.L (2000). Treatment of binge-eating disorder with topiramate: A clinical case series. Journal of Clinical Psychiatry, 61, 368-372.
22. Steward, A.L., & Ware, J.E. (1992). Measuring functioning and well-being. Durham, NC: Duke University Press.
23. Teter, C.J., Early, J.J., & Gibbs, C.M. (2000). Treatment of affective disorder and obesity with topiramate. Annals of Pharmacotherapy, 34, 1262-1265.